Castleman disease

Christopher Hoffmann, M.D., M.P.H., Mark Levis, M.D., Ph.D.
Castleman disease is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

PATHOGENS

  • HIV-associated multicentric Castleman disease (MCD) always associated with HHV-8, aka Kaposi sarcoma-associated herpesvirus (KSHV). HHV-8 present in 40% of non-HIV cases.
  • HHV-8 is a double-stranded DNA gamma-herpesvirus.
  • MCD is likely the result of active lytic infection with all viral genes expressed and viral replication as opposed to a very small proportion of HHV-8 cells (1%) having lytic infection in Kaposi sarcoma.
  • HHV-8 is secreted in saliva (possible reason for high MSM prevalence of HHV-8 infection in the U.S. is through oral anal infection, unclear reasons for high general population infection in Africa).

-- To view the remaining sections of this topic, please or --

PATHOGENS

  • HIV-associated multicentric Castleman disease (MCD) always associated with HHV-8, aka Kaposi sarcoma-associated herpesvirus (KSHV). HHV-8 present in 40% of non-HIV cases.
  • HHV-8 is a double-stranded DNA gamma-herpesvirus.
  • MCD is likely the result of active lytic infection with all viral genes expressed and viral replication as opposed to a very small proportion of HHV-8 cells (1%) having lytic infection in Kaposi sarcoma.
  • HHV-8 is secreted in saliva (possible reason for high MSM prevalence of HHV-8 infection in the U.S. is through oral anal infection, unclear reasons for high general population infection in Africa).

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 5, 2017